SynCell Biotechnology’s MALSI 2020 experience 

SynCell News • August 28, 2020

Last week, SynCell Biotechnology was invited to pitch some of our latest technological innovations at MALSI+ 2020, a virtual conference organized by the Massachusetts Technology Transfer Center to brings together major public and private entities in the State that are committed to building the next generation of Massachusetts companies 

In this entirely virtual 2020’s event, around 700 registrations and two excellent panels about the CEO perspective and the weight of inventions in a scientific career were the main protagonists, counting with active community scientists, post-docs, professors, entrepreneurs, innovators, and venture capitalists 

Besides, 17 different companies were invited to the conference to pitch their work and selected to win two cash prices: the judge’s approval and the public rating. In this second category, SynCell was chosen as the third best presentation, which was possible thanks to the great work of our team and the help of those who voted for us.  

In this event, our co-founder and active member Ada Vernet-Crua represented the interest of the company with a 60 seconds elevator pitch deck that was transmitted to the entire conference, and a 5-minute pitch deck that was delivered in two separate sessions during the event for those who showed interest in the technological innovations that we are developing.  

The entire team of SynCell Biotechnology sincerely recommends MALSI+ as an excellent opportunity to learn and connect with scientific innovators, entrepreneurs, business leaders, and investors in a friendly environment, and we hope to be able to participate in the next edition.